104 related articles for article (PubMed ID: 17130580)
1. Thiazolidinediones may not reduce diabetes incidence in type 1 diabetes.
Shigihara T; Okubo Y; Kanazawa Y; Oikawa Y; Shimada A
Ann N Y Acad Sci; 2006 Oct; 1079():365-8. PubMed ID: 17130580
[TBL] [Abstract][Full Text] [Related]
2. Prevention of diabetes in the nonobese diabetic mouse by oral immunological treatments. Comparative efficiency of human insulin and two bacterial antigens, lipopolysacharide from Escherichia coli and glycoprotein extract from Klebsiella pneumoniae.
Saï P; Rivereau AS
Diabetes Metab; 1996 Oct; 22(5):341-8. PubMed ID: 8896996
[TBL] [Abstract][Full Text] [Related]
3. Metformin does not alter diabetes incidence in the NOD mouse.
Beales PE; Giorgini A; Annovazzi A; Signore A; Parlapiano C; Pozzilli P
Horm Metab Res; 1997 Jun; 29(6):261-3. PubMed ID: 9230345
[TBL] [Abstract][Full Text] [Related]
4. Lack of effect of vitamin D administration during pregnancy and early life on diabetes incidence in the non-obese diabetic mouse.
Hawa MI; Valorani MG; Buckley LR; Beales PE; Afeltra A; Cacciapaglia F; Leslie RD; Pozzilli P
Horm Metab Res; 2004 Sep; 36(9):620-4. PubMed ID: 15486813
[TBL] [Abstract][Full Text] [Related]
5. The influence of oral insulin on the development of autoimmune diabetes in NOD mice fed a hypoallergenic diet.
Shehadeh N; Weis R; Teninboum G; Benderly A; Etzioni A; Shamir R
Diabetes Nutr Metab; 2004 Feb; 17(1):1-5. PubMed ID: 15163117
[TBL] [Abstract][Full Text] [Related]
6. IL-12 plays a pathologic role at the inflammatory loci in the development of diabetes in NOD mice.
Nitta Y; Kawamoto S; Tashiro F; Aihara H; Yoshimoto T; Nariuchi H; Tabayashi K; Miyazaki J
J Autoimmun; 2001 Mar; 16(2):97-104. PubMed ID: 11247635
[TBL] [Abstract][Full Text] [Related]
7. Cannabidiol lowers incidence of diabetes in non-obese diabetic mice.
Weiss L; Zeira M; Reich S; Har-Noy M; Mechoulam R; Slavin S; Gallily R
Autoimmunity; 2006 Mar; 39(2):143-51. PubMed ID: 16698671
[TBL] [Abstract][Full Text] [Related]
8. [Effects of pravastatin in prevention of diabetes and mechanism thereof: experiment with non-obese diabetic mice].
Zhang S; Yan X; Zhou PC; Huang C; Yang L; Li X; Lin J; Zhou ZG
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):568-72. PubMed ID: 18649776
[TBL] [Abstract][Full Text] [Related]
9. [Inhibition of islet beta cell apoptosis and prevention diabetes by subcutaneous administration of insulin in NOD mice].
Jiang TJ; Zhou ZG; Su H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 31(4):499-504. PubMed ID: 16951506
[TBL] [Abstract][Full Text] [Related]
10. Synthetic glycolipid OCH prevents insulitis and diabetes in NOD mice.
Mizuno M; Masumura M; Tomi C; Chiba A; Oki S; Yamamura T; Miyake S
J Autoimmun; 2004 Dec; 23(4):293-300. PubMed ID: 15571923
[TBL] [Abstract][Full Text] [Related]
11. Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-gamma expression in splenic T cells.
Augstein P; Dunger A; Heinke P; Wachlin G; Berg S; Hehmke B; Salzsieder E
Biochem Biophys Res Commun; 2003 May; 304(2):378-84. PubMed ID: 12711326
[TBL] [Abstract][Full Text] [Related]
12. Immunolocalization of monocyte chemoattractant protein-1 in islets of NOD mice during cyclophosphamide administration.
Reddy S; Bai Y; Robinson E; Ross J
Ann N Y Acad Sci; 2006 Oct; 1079():103-8. PubMed ID: 17130538
[TBL] [Abstract][Full Text] [Related]
13. Coxsackievirus immunization delays onset of diabetes in non-obese diabetic mice.
Davydova B; Härkönen T; Kaialainen S; Hovi T; Vaarala O; Roivainen M
J Med Virol; 2003 Apr; 69(4):510-20. PubMed ID: 12601759
[TBL] [Abstract][Full Text] [Related]
14. [Mechanisms of human glutamic acid decarboxylase 65 DNA vaccine preventing diabetes in non-obese diabetic mice].
Luo JH; Zhou ZG; Jiang TJ; Pei JH; Li X; He L; Sun SG
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1791-5. PubMed ID: 15631776
[TBL] [Abstract][Full Text] [Related]
15. Gluten-free but also gluten-enriched (gluten+) diet prevent diabetes in NOD mice; the gluten enigma in type 1 diabetes.
Funda DP; Kaas A; Tlaskalová-Hogenová H; Buschard K
Diabetes Metab Res Rev; 2008; 24(1):59-63. PubMed ID: 17607660
[TBL] [Abstract][Full Text] [Related]
16. Oral administration of insulin to neonates suppresses spontaneous and cyclophosphamide induced diabetes in the NOD mouse.
Maron R; Guerau-de-Arellano M; Zhang X; Weiner HL
J Autoimmun; 2001 Feb; 16(1):21-8. PubMed ID: 11221993
[TBL] [Abstract][Full Text] [Related]
17. Attempt to prevent the development of diabetes in non-obese diabetic mice by oral vanadate administration.
Meyerovitch J; Waner T; Sack J; Kopolovic J; Shemer J
Isr Med Assoc J; 2000 Mar; 2(3):211-4. PubMed ID: 10774269
[TBL] [Abstract][Full Text] [Related]
18. Protection of IFN-gamma signaling-deficient NOD mice from diabetes by cyclophosphamide.
Mori Y; Kato T; Kodaka T; Kanagawa EM; Hori S; Kanagawa O
Int Immunol; 2008 Sep; 20(9):1231-7. PubMed ID: 18644830
[TBL] [Abstract][Full Text] [Related]
19. G-CSF treatment prevents cyclophosphamide acceleration of autoimmune diabetes in the NOD mouse.
Hadaya K; Kared H; Masson A; Chatenoud L; Zavala F
J Autoimmun; 2005 Mar; 24(2):125-34. PubMed ID: 15829405
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic fenbendazole therapy does not affect the incidence and onset of type 1 diabetes in non-obese diabetic mice.
Franke DD; Shirwan H
Int Immunol; 2006 Mar; 18(3):453-8. PubMed ID: 16415097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
